Pricing Log in Create free account
Friday 6 November 2026 Export KOD’s income statement to Excel — free account

Kodiak Sciences Inc.

KOD Healthcare Biotechnology

EPS
−1.94%
Free cash flow
−33.9%

Quarter to June 2026, against a year earlier

98.85 7.83 +8.60%
Market cap
$5.7B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Valuation Filings

Kodiak Sciences Inc. (KOD) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Sep 28, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2026 P1I2: 6 added · 2 removed · 28 modified
P2I1A: no comparison — low extraction confidence 		Share dilution Short cash runway
8-K Aug 13, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 2, 2026 5.07 Submission of matters to a vote of security holders
10-Q Mar 31, 2026
8-K May 7, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 24 added · 27 removed · 45 modified
1A: 23 added · 8 removed · 77 modified
7: 23 added · 32 removed · 29 modified
8-K Mar 31, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Mar 26, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Dec 16, 2025 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Nov 13, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
8-K Aug 13, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K May 14, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2024
8-K Mar 27, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Nov 14, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Aug 14, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 15, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Mar 28, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Nov 14, 2023 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.